Clincosm LogoSign in Get a demo

Recurrent Ovarian Carcinoma

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma

Active, not recruiting
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Anchorage, Alaska
  • +584 more
Jan 28, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +14 more
  • Birmingham, Alabama
  • +399 more
Dec 30, 2022

Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

Active, not recruiting
  • Metastatic Fallopian Tube Carcinoma
  • +11 more
  • Phoenix, Arizona
  • +13 more
Dec 2, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Active, not recruiting
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Ipilimumab
  • Nivolumab
  • Auburn, California
  • +205 more
Oct 18, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Phoenix, Arizona
  • +14 more
Sep 1, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Recurrent Endometrial Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Aurora

Active, not recruiting
  • Recurrent Endometrial Serous Adenocarcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
May 24, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +44 more
Jan 10, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +17 more
  • Phoenix, Arizona
  • +162 more
Sep 28, 2021

Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Carcinoma Trial in Korea, Republic of, United States (Laboratory Biomarker

Completed
Has Results
  • Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Carcinoma
  • Laboratory Biomarker Analysis
  • Sunitinib Malate
  • Birmingham, Alabama
  • +96 more
Feb 6, 2020

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Bevacizumab
  • +4 more
  • Aurora, Colorado
  • +12 more
Jul 19, 2019

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in United States (Paclitaxel

Completed
Has Results
  • Fallopian Tube Carcinoma
  • +2 more
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
  • Aurora, Colorado
  • +19 more
Dec 14, 2017

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1
  • Birmingham, Alabama
  • +10 more
Dec 13, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016